Navigation Links
Valeant Pharmaceuticals Provides Update to Recent Event
Date:4/4/2013

/p>

Forward Looking Statements

This press release contains forward-looking statements regarding, among other things, the ability of our business model to deal with unexpected events, the launch of our authorized generic of Zovirax ointment, the financial impact of the genericization of Zovirax ointment, and our 2013 performance.  Statements including words such as "believes," "expects," "anticipates," "intends," "estimates," "plan," "will," "may," "intend," "guidance" or similar expressions are forward-looking statements.  Because these statements reflect Valeant's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties. Investors should note that many factors could cause actual results to differ materially from those expressed in forward-looking statements contained in this press release. These factors include, but are not limited to the market acceptance of our authorized generic Zovirax ointment, the impact of the genericization of Zovirax ointment and other risks and uncertainties, including those detailed from time to time in Valeant's periodic reports filed with the Securities and Exchange Commission ("SEC") and the Canadian Securities Administrators ("CSA"), including current reports on Form 8-K, quarterly reports on Form 10-Q and annual report on Form 10-K, particularly the discussion under the caption "RISK FACTORS" in Valeant's annual reports on Form 10-K for the year ended December 31, 2012, which have been filed with the SEC and the CSA. The forward-looking statements in this press release are qualified by these risk factors. These are factors that, individually or in the aggregate, could cause Valeant's actual results to differ materially from expected and historical results. Valeant assumes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.

Contact Information:


'/>"/>
SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
2. Valeant Pharmaceuticals Announces Private Exchange Offer
3. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
4. Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
5. Valeant Completes Acquisition Of Natur Produkt In Russia
6. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
7. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
8. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
9. Valeant Pharmaceuticals Announces New Management Appointments
10. Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
11. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... , July 1, 2015 Jazz Pharmaceuticals plc (Nasdaq: ... webcasting its corporate presentation at the Cantor Fitzgerald Healthcare Conference ... Russell Cox , executive vice president ... company and a business and financial update on Wednesday, July ... A live audio webcast of the presentation ...
(Date:7/1/2015)... Lilly and Company (NYSE: LLY ) will announce its ... July 23, 2015. Lilly will also conduct a conference call ... further detail the company,s financial performance. The conference ... the general public can access a live webcast of the ... Lilly,s website at www.lilly.com . A replay will also ...
(Date:7/1/2015)... , July 1, 2015  goBalto, Inc., ... solutions, announced today unprecedented growth in serving pharmaceutical, ... intense pressure to speed clinical trials and restrain ... and paper-based methods have stalled these efforts," said ... status of clinical trials has encouraged Industry leaders, ...
Breaking Medicine Technology:Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement 2goBalto Triples Sites Managed, Further Reinforcing Market Leadership Position 2
... HARLEYSVILLE, Pa. and LUDWIGSHAFEN, Germany, Oct. 20, 2011 ... the development of future film coating systems using Kollicoat® ... Colorcon has developed a pre-formulated additive ... enables efficient preparation and application of this polymer in ...
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today ... management to discuss third quarter 2011 financial results, as well ... 2011, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). ... will be released earlier that day. Interested parties ...
Cached Medicine Technology:Colorcon and BASF Announce Collaboration to Develop Film Coating Applications Using Kollicoat® Smartseal 30 D 2
(Date:7/2/2015)... ... July 02, 2015 , ... ... their products, services, channels and business models. To help manage the increasing demand ... addition of Mark Benkendorf as SVP of Strategic Engagements. , Benkendorf is a ...
(Date:7/1/2015)... ... 2015 , ... In the United States, summer has always been the season ... Arabia and Dubai, the summer temperatures are so hot, that July vacationers often leave ... Saleh of ORA Dentistry Spa notes that a trip to the United States, and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Dr. ... Georgia State University and a Georgia Research Alliance Eminent Scholar in Inflammation and ... therapeutics against middle-ear infections. , The grant from the National Institute on Deafness ...
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court overseeing a ... has granted the Defendants’ Motion for Summary Judgment. According to an Order issued ... the Court rejected the Plaintiff’s assertion that one manufacturer can be held ...
(Date:7/1/2015)... ... July 01, 2015 , ... There ... liberty. Americans have been arguing over laws governing sexuality since the first Pilgrims ... a forthcoming historical comparative biography by Cindy Safronoff reveals. Crossing Swords: Mary Baker ...
Breaking Medicine News(10 mins):Health News:Business Builder Mark Benkendorf Joins Innovation Firm Maddock Douglas 2Health News:Dr. Sam Saleh Invites Vacationing International Patients to Get a Same-Day Hollywood Smile During the July Travel Season 2Health News:Institute for Biomedical Sciences Researcher Gets $1.6 Million to Develop Anti-Inflammatory Drug 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 2Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 3Health News:Biography by Cindy Safronoff to be Released July 4 Explores an 1870s Marriage Debate Over Women’s Rights and the Implications of the American Revolution for Sexuality 4
... , , DALLAS, Sept. 11 ... (OTC Bulletin Board: ACCP) has entered into an agreement with ... distribution. One or more U.S. market seeding studies could begin as ... In a comparison of cancer patients receiving standard oral mucositis care with ...
... NEW YORK, Sept. 11 The NY Chiropractic ... ("PCA"), the Association of New Jersey Chiropractors ("ANJC"), fourteen ... have sued as the class representatives of the putative class. ... Gross LLP and co-counsel Buttaci & Leardi, LLC, have filed ...
... heavy traffic noise had raised readings , FRIDAY, Sept. ... be bad for your blood pressure, a new study suggests. ... horns honking and brakes screeching have an increased risk of ... of Environmental Health . , A team from Lund ...
... study has found that two genes in mice were associated ... These findings give researchers new hope for developing more effective ... outcomes. This study will be presented at the Congress of ... in Dusseldorf, Germany, on Sept. 11, 2009. "Most ...
... , CUPERTINO, Calif., Sept. 11 ... reported that it has entered into a privately negotiated transaction ... of Venrock at a price of $2.25 per share, raising ... expects the financing to close on or about September 18, ...
... DUBLIN, Ohio, Sept. 11 Cardinal Health today announced the ... to purchase up to an aggregate purchase price of $1.2 billion ... tender offer is part of a previously announced plan to reduce ... of CareFusion Corp. and includes notes issued by both Cardinal Health ...
Cached Medicine News:Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 2Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 3Health News:Access Pharmaceuticals Signs Agreement to Manufacture Its FDA-Approved MuGard in the United States 4Health News:Blue Cross and Blue Shield Sued by Health Care Providers for Abusive Practices 2Health News:Blue Cross and Blue Shield Sued by Health Care Providers for Abusive Practices 3Health News:Busy Roads Boost Blood Pressure 2Health News:Mayo Clinic identifies 2 genes as potential therapeutic targets for multiple sclerosis 2Health News:DURECT Announces Sale of 4,444,444 Shares of Common Stock, Raising Proceeds of $10 Million 2Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 2Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 3Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 4Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 5Health News:Cardinal Health Announces Early Tender Results of Debt Tender Offer 6
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (P3797) ... assistance. Color: colour-coded ...
... PYREX serological pipets are calibrated "to deliver" ... use in confined areas such as hoods. ... and feature negative and reverse graduations to ... measuring procedures. Packaged in plastic bags so ...
Corning 7078A multi-pack plugged capacity 5 mL...
Corning 7077B L 215 mm volume 5.0 0.1 mL...
Medicine Products: